- recruitingPHASE3
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
This study looks at the long-term safety of a medicine called guselkumab for children and young people with Crohn's disease, ulcerative colitis, or a type of arthritis called juvenile psoriatic arthritis. It's for those who have already seen benefits from the medicine in an earlier study.
United States · Argentina · Australia - active not recruitingPHASE3
A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
This study is looking into two medicines, ustekinumab and guselkumab, for children and young people aged 5-17 with juvenile psoriatic arthritis. We want to see how well these medicines work, if they are safe, and how the body handles them to help manage this type of arthritis.
United States · Argentina · Denmark